Pharmaceutical Benefits Report - Structured Content Specification v1.1.1

Name
NEHTA-1699:2014 Pharmaceutical Benefits Report - Structured Content Specification v1.1.1
Identifier
NEHTA-1699:2014
Version
1.1.1
Date
15-09-2014

This document describes the structured content specification for the Pharmaceutical Benefits Report.

The content within this document provides reviewers (software development teams, architects, designers, clinicians and informatics researchers) with the necessary information (or references to information held outside this document) to evaluate and assess the clinical suitability of Agency-endorsed specifications for the electronic transfer of Pharmaceutical Benefits Reports.

It is also a key input to the Pharmaceutical Benefits Report CDA Implementation Guide which describes how to implement Agency-compliant Pharmaceutical Benefits Reports using the HL7 Clinical Document Architecture.

This specification references or contains excerpts of intellectual property (IP) owned by the Regenstrief Institute, IHTSDO, or HL7 International. Applicable IP constraints apply:

  • This material contains content from LOINCTM (http://loinc.org). The LOINC table, LOINC codes, and LOINC panels and forms file are copyright © 1995-2015, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and available at no cost under the license at http://loinc.org/terms-of-use. LOINC is a trademark of Regenstrief Institute, Inc., registered in the United States.
  • This material includes SNOMED Clinical TermsTM (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO). All rights reserved. SNOMED CT®, was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO, (http://www.ihtsdo.org).
  • This document includes excerpts of HL7TM International standards and other HL7 International material. HL7 International is the publisher and holder of copyright in the excerpts. The publication, reproduction and use of such excerpts is governed by the HL7 IP Policy (see http://www.hl7.org/legal/ippolicy.cfm) and the HL7 International License Agreement. HL7 and CDA are trademarks of Health Level Seven International and are registered with the United States Patent and Trademark Office.